Structured, physician-led weight management for adults in South Delhi — metabolic assessment, lifestyle redesign, and supervised GLP-1 therapy (Ozempic, Wegovy, Mounjaro) where clinically appropriate.
Obesity is a chronic metabolic condition, not a willpower problem. The consultation starts with a full metabolic work-up — HbA1c, insulin resistance, lipids, liver and thyroid function, vitamin status — so the plan addresses the underlying biology, not just calories.
When GLP-1 therapy is considered
Semaglutide (Ozempic / Wegovy) and tirzepatide (Mounjaro / Zepbound) are powerful tools when used correctly — typically for BMI ≥ 27 with a weight-related condition or BMI ≥ 30. We assess eligibility, manage side effects, monitor labs, and integrate the medicine with diet, protein, sleep and movement.
Lifestyle plan you can actually live with
Realistic dietary patterns suited to Indian kitchens, a protein and fibre target, sleep and stress review, and a movement plan calibrated to your joints and schedule. We track waist circumference, body composition where available, and metabolic markers — not just the scale.
Who this is for
Patients with obesity, pre-diabetes, Type 2 diabetes, PCOS-related weight gain, fatty liver, post-pregnancy weight retention, or executives seeking a sustainable plan after years of failed attempts. Consultations available at Friends Colony East and Maharani Bagh.
Frequently asked
Who is the best doctor for weight management in South Delhi?
Dr. Sanjay Sachdev (MBBS, MNAMS) runs a structured medical weight-management practice in Friends Colony and Maharani Bagh — combining metabolic work-up, lifestyle redesign, and where appropriate, GLP-1 therapy (Ozempic, Wegovy, Mounjaro).
When is medication like Ozempic or Mounjaro appropriate for weight loss?
GLP-1 receptor agonists are considered when BMI ≥ 27 with a weight-related condition (diabetes, hypertension, fatty liver, OSA) or BMI ≥ 30 — alongside diet, activity and behaviour change, not as a substitute.
How much weight can I realistically lose?
Structured medical weight management typically delivers 7–15% body-weight loss in 6–12 months; GLP-1 therapy in eligible patients can extend this to 15–22% with sustained use and lifestyle change.
Will the weight come back if I stop the medication?
Partly — that's why we treat obesity as a chronic condition. We plan the transition off medication carefully with intensified lifestyle support, and many patients maintain most of their loss with a structured maintenance plan.
What tests are done before starting weight-management treatment?
Baseline includes HbA1c, fasting insulin, lipid profile, liver and kidney function, TSH, vitamin D and B12, and a metabolic and family-history review. We screen for fatty liver and sleep apnoea where indicated.